Cargando…
P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431122/ http://dx.doi.org/10.1097/01.HS9.0000849372.14120.8e |
| _version_ | 1784779965489741824 |
|---|---|
| author | Thomopoulos, T. Bouchla, A. Antoniadou, A. Terpos, E. Politou, M. Stamoulis, K. Koromboki, E. Papageorgiou, S. Kotanidou, A. Kalomenidis, I. Jahaj, E. Grigoropoulou, S. Pagoni, M. Grouzi, E. Poulakou, G. Trontzas, I. Labropoulou, S. Mentis, A. Bamias, A. Tsiodras, S. Dimopoulos, M.-A. Pappa, V. |
| author_facet | Thomopoulos, T. Bouchla, A. Antoniadou, A. Terpos, E. Politou, M. Stamoulis, K. Koromboki, E. Papageorgiou, S. Kotanidou, A. Kalomenidis, I. Jahaj, E. Grigoropoulou, S. Pagoni, M. Grouzi, E. Poulakou, G. Trontzas, I. Labropoulou, S. Mentis, A. Bamias, A. Tsiodras, S. Dimopoulos, M.-A. Pappa, V. |
| author_sort | Thomopoulos, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431122 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94311222022-08-31 P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL Thomopoulos, T. Bouchla, A. Antoniadou, A. Terpos, E. Politou, M. Stamoulis, K. Koromboki, E. Papageorgiou, S. Kotanidou, A. Kalomenidis, I. Jahaj, E. Grigoropoulou, S. Pagoni, M. Grouzi, E. Poulakou, G. Trontzas, I. Labropoulou, S. Mentis, A. Bamias, A. Tsiodras, S. Dimopoulos, M.-A. Pappa, V. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431122/ http://dx.doi.org/10.1097/01.HS9.0000849372.14120.8e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Thomopoulos, T. Bouchla, A. Antoniadou, A. Terpos, E. Politou, M. Stamoulis, K. Koromboki, E. Papageorgiou, S. Kotanidou, A. Kalomenidis, I. Jahaj, E. Grigoropoulou, S. Pagoni, M. Grouzi, E. Poulakou, G. Trontzas, I. Labropoulou, S. Mentis, A. Bamias, A. Tsiodras, S. Dimopoulos, M.-A. Pappa, V. P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title | P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title_full | P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title_fullStr | P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title_full_unstemmed | P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title_short | P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL |
| title_sort | p1629: administration of convalescent plasma for the treatment of severe covid-19: results of a multicenter phase ii trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431122/ http://dx.doi.org/10.1097/01.HS9.0000849372.14120.8e |
| work_keys_str_mv | AT thomopoulost p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT bouchlaa p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT antoniadoua p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT terpose p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT politoum p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT stamoulisk p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT korombokie p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT papageorgious p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT kotanidoua p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT kalomenidisi p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT jahaje p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT grigoropoulous p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT pagonim p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT grouzie p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT poulakoug p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT trontzasi p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT labropoulous p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT mentisa p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT bamiasa p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT tsiodrass p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT dimopoulosma p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial AT pappav p1629administrationofconvalescentplasmaforthetreatmentofseverecovid19resultsofamulticenterphaseiitrial |